134 related articles for article (PubMed ID: 30732667)
1. How Procurement Judges The Value of Medical Technologies: A Review of Healthcare Tenders.
Miller FA; Lehoux P; Peacock S; Rac VE; Neukomm J; Barg C; Bytautas JP; Krahn M
Int J Technol Assess Health Care; 2019 Jan; 35(1):50-55. PubMed ID: 30732667
[TBL] [Abstract][Full Text] [Related]
2. Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime.
Miller FA; Lehoux P; Rac VE; Bytautas JP; Krahn M; Peacock S
Soc Sci Med; 2020 Nov; 265():113528. PubMed ID: 33261901
[TBL] [Abstract][Full Text] [Related]
3. Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage.
Maniadakis N; Holtorf AP; Otávio Corrêa J; Gialama F; Wijaya K
Appl Health Econ Health Policy; 2018 Oct; 16(5):591-607. PubMed ID: 29987759
[TBL] [Abstract][Full Text] [Related]
4. IMPACT OF HEALTH TECHNOLOGY ASSESSMENT REPORTS ON HOSPITAL DECISION MAKERS - 10-YEAR INSIGHT FROM A HOSPITAL UNIT IN SHERBROOKE, CANADA: IMPACT OF HEALTH TECHNOLOGY ASSESSMENT ON HOSPITAL DECISIONS.
Poder TG; Bellemare CA; Bédard SK; Fisette JF; Dagenais P
Int J Technol Assess Health Care; 2018 Jan; 34(4):393-399. PubMed ID: 30021663
[TBL] [Abstract][Full Text] [Related]
5. Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices.
Barbier L; Simoens S; Soontjens C; Claus B; Vulto AG; Huys I
Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073861
[TBL] [Abstract][Full Text] [Related]
6. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
Allen N; Walker SR; Liberti L; Salek S
Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
[TBL] [Abstract][Full Text] [Related]
7. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
[TBL] [Abstract][Full Text] [Related]
8. Determining when integrated delivery systems should belong to GPOs.
Smith CR
Healthc Financ Manage; 1998 Sep; 52(9):38-41. PubMed ID: 10182741
[TBL] [Abstract][Full Text] [Related]
9. HEALTH TECHNOLOGY ASSESSMENT IN SERBIA.
Atanasijevic D; Zah V
Int J Technol Assess Health Care; 2017 Jan; 33(3):384-389. PubMed ID: 28662733
[TBL] [Abstract][Full Text] [Related]
10. CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN HEALTHCARE SYSTEM IN SLOVENIA.
Prevolnik Rupel V
Int J Technol Assess Health Care; 2017 Jan; 33(3):360-364. PubMed ID: 28434423
[TBL] [Abstract][Full Text] [Related]
11. DEVELOPMENT OF HEALTH TECHNOLOGY ASSESSMENT IN ROMANIA.
Scintee SG; Ciutan M
Int J Technol Assess Health Care; 2017 Jan; 33(3):371-375. PubMed ID: 28436346
[TBL] [Abstract][Full Text] [Related]
12. QUALITY OF HEALTH TECHNOLOGY ASSESSMENT REPORTS PREPARED FOR THE MEDICAL SERVICES ADVISORY COMMITTEE.
Hua M; Boonstra T; Kelly PJ; Wilson A; Craig JC; Webster AC
Int J Technol Assess Health Care; 2016 Jan; 32(4):315-323. PubMed ID: 27691988
[TBL] [Abstract][Full Text] [Related]
13. [French national overview of the inclusion of environmental criteria in the public purchasing of health products (drugs and sterile medical devices)].
Giraud JS; Hamidou F; Hassani Y; Borel C; Le Gonidec P
Ann Pharm Fr; 2022 Mar; 80(2):216-226. PubMed ID: 34153241
[TBL] [Abstract][Full Text] [Related]
14. HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.
Polisena J; Castaldo R; Ciani O; Federici C; Borsci S; Ritrovato M; Clark D; Pecchia L
Int J Technol Assess Health Care; 2018 Jan; 34(3):276-289. PubMed ID: 29909792
[TBL] [Abstract][Full Text] [Related]
15. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion.
Diaby V; Goeree R; Hoch J; Siebert U
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):13-9. PubMed ID: 25267699
[TBL] [Abstract][Full Text] [Related]
16. INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.
Martelli N; Billaux M; Borget I; Pineau J; Prognon P; van den Brink H
Int J Technol Assess Health Care; 2015 Jan; 31(1-2):12-8. PubMed ID: 25991072
[TBL] [Abstract][Full Text] [Related]
17. Effects of procurement practices on quality of medical device or service received: a qualitative study comparing countries.
Lingg M; Wyss K; Durán-Arenas L
BMC Health Serv Res; 2016 Aug; 16(a):362. PubMed ID: 27501691
[TBL] [Abstract][Full Text] [Related]
18. USING THE HEALTH TECHNOLOGY ASSESSMENT TOOLBOX TO FACILITATE PROCUREMENT: THE CASE OF SMART PUMPS IN A CANADIAN HOSPITAL.
Poder TG
Int J Technol Assess Health Care; 2017 Jan; 33(1):54-62. PubMed ID: 28578750
[TBL] [Abstract][Full Text] [Related]
19. Value-based procurement: Canada's healthcare imperative.
Prada G
Healthc Manage Forum; 2016 Jul; 29(4):162-4. PubMed ID: 27278137
[TBL] [Abstract][Full Text] [Related]
20. Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?
Menon D; Clark D; Stafinski T
Healthc Policy; 2015 Aug; 11(1):15-32. PubMed ID: 26571466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
